The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patients

Paul P. Dobesh, Tania Ahuja, George A. Davis, Hugh Fatodu, William H. Francis, Frank P. Hull, Gary L. Johnson, Joshua D Lenchus, Jacqueline Glee Lenoir, Claudette McPherson, Jeffrey Nemeth, Ralph J. Riello

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)S475-S482
JournalThe American journal of managed care
Volume24
Issue number22
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Health Policy

Cite this

Dobesh, P. P., Ahuja, T., Davis, G. A., Fatodu, H., Francis, W. H., Hull, F. P., Johnson, G. L., Lenchus, J. D., Lenoir, J. G., McPherson, C., Nemeth, J., & Riello, R. J. (2018). The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patients. The American journal of managed care, 24(22), S475-S482.